Introduction
Polysubstituted tetrahydrofurans are common structural motifs found in natural products and biologically active molecules such as annonaceous acetogenins, 1 lignans, 2 polyether ionophores 3 and macrodiolides. 4 Due to their biological activities including antitumour, antihelmic, antimalarial, antimicrobial and antiprotozoal activity as well as challenging structures, development of methods for synthesizing differently substituted tetrahydrofurans stereoselectively have become important. There are many approaches described in the literature for the formation of tetrahydrofuran ring systems. 5 They include oxidative cyclisation, 6 radical cyclisation, 7 cycloisomerisation, 8 Prins/Prins-Pinacol type cyclisation, 9 Palladium mediated Tsuji-Trost allylation reaction 10 among others (Fig. 1) .
The marine environment has frequently afforded a variety of biologically active compounds with strong anticancer and Department of Chemistry, School of Chemical Technology, Aalto University, P.O. Box 16100 (Kemistintie 1), FI-00076, Aalto, Finland. Fig. 1 Some examples for the preparation of tetrahydrofuran/dihydrofuran ring systems. cytotoxic properties. Pachastrissamine (Jaspine B) 1 (Fig. 2) , the first naturally occurring anhydrosphingosine derivative, was isolated in 2001 by Higa and co-workers 11 from an Okinawan marine sponge Pachastrissa sp. (family calthropellidae). Later in 2003 Debitus and co-workers 12 isolated the same compound from a Vanuatuan marine sponge genus Jaspis. It was found to possess marked cytotoxicity at a level of IC 50 0.01 mg mL -1 against P388, A549, HT29 and Mel 28 cell lines. Due to the biological activity and challenging chemical structure, a great deal of effort has been devoted to the synthesis of Pachastrissamine 13 including our own. 14 Lesser, but lately increasing, attention has been paid to the synthesis of other diastereomers of Pachastrissamine. Delgado and co-workers 13q and Ohno and co-workers 13x have both synthesized four diastereomers of Pachastrissamine (1, C 2 epimer 2, C 2 &C 3 epimer 3 and C 3 epimer 4) and other groups only the epimer 2. 13c,k,n,s Herein, we report a short synthesis of all four diastereomers of Pachastrissamine from Garner's aldehyde.
Results and discussion
Our synthetic plan is depicted in Scheme 1. Retrosynthetically the carbon skeleton of 1 can be considered to arise from a cross metathesis reaction of a vinyltetrahydrofuran and a terminal alkene. We anticipated that the (2, 3, 4) -substituted tetrahydrofuran framework, the key intermediate of our route, could be achieved via an h 3 -allylpalladium intermediate. Depending on the selectivity of the cyclization step both isomers at C 2 should be achievable. After simple functional group manipulations the synthon for the tetrahydrofuran framework can be envisaged to arise from an allylic oxazoline, which itself can be derived from a stereoselective coupling of Garner's aldehyde 5 with a suitably protected vinyliodide 6.
The synthesis commenced with the preparation of Z-iodide 6 (Scheme 2). We first attempted a route first published by Luithle and Pietruszka. 15 Propargyl alcohol 7 was protected as a silyl ether with TBSCl (93%). 16 The TBS ether 8 was then subjected to iodination with elemental iodine at -78 • C (61%). 17 The triple bond of 9 was reduced with diimide (HN NH) 18 to give the Z-double bond in a modest yield (30%) with the overall yield being just 17% (over three steps). The poor yield of the reduction reaction is partly explained by overreduction of the triple bond to single bond. By simply changing the order of reactions the overall yield improved to 51%. Iodination of propargyl alcohol 7 provided iodide 10 19 in good yield (82%). The yield is lowered due to the high volatility of the iodide 10 (despite it being crystalline). This iodide can be distilled under vacuum (10) (11) (12) (13) (14) (15) . N.B. Iodide 10 is explosive at high temperatures! Diimide reduction of 10 proceeded smoothly to provide the Z-alkene 11 20 in a fairly good yield (65%). TBS protection proceeded with ease providing the Z-iodide 6 21 in almost quantitative yield (96%). This three step procedure can be performed with a single purification process, distillation of the final Z-iodide 6.
Nucleophilic addition to Garner's aldehyde has been very thoroughly studied. 22 Pioneering research was done separately by Herold 22a and Garner. 22b The stereochemical outcome can be controlled either through the use of additives or chelating agents. HMPA is known to solvate lithium cations very well. This coordination enhances the nucleophilicity of the lithiated species, which favours the attack of the nucleophile from the least hindered side via a Felkin-Ahn transition state (leading to anti-diastereomer). Bidentate metal cations (e.g. Mg, Zn) tend to chelate to the carbonyl groups and affect the stereochemical outcome. Under chelation control syn-diastereomers are produced as major products. Iodide 6 was then coupled with Garner's aldehyde 5 (Scheme 3). anti/syn-Selectivities are reported in Table 1 . High anti-selectivity (upto 17 : 1 anti/syn) was best achieved with DMPU or HMPA as an additive. Without additives the selectivity Yields of these coupling reactions varied between 40-70% depending on the reaction conditions. Alcohols 12a and 12b were protected as benzyl ethers with BnBr, TBAI and NaH in refluxing THF in a good yield (for 13a 96% and for 13b 92%). Removal of the TBS protecting groups from 13a/b with TBAF proceeded quickly and smoothly providing alcohols 14a (90%) or 14b (92%) in excellent yields (Scheme 4). The reaction was instantly over with both diastereomers 13a/b as soon as 100 mol% of TBAF had been added. Free alcohols 14a/b were esterified with Ac 2 O, DMAP/Et 3 N in CH 2 Cl 2 . Again, this reaction proved to be fast and efficient Full conversion was reached with both diastereomers 14a/b within 5 min after the addition of the anhydride (isolated yield with both 15a and 15b 95%). Cleavage of the N,O-acetal was best achieved with FeCl 3 adsorbed on silica gel in CHCl 3 . 23 80% AcOH at 50 • C can also be used, but on larger scales this reagent esterifies the newly formed free alcohol to some extent.
The key reaction, cyclization into a furan ring, we had envisioned to proceed via an allylpalladium intermediate. 10, 24 It is known that with chiral allylic acetates (or esters in general) in the formation of the allylpalladium complex, the initial attack of Pd 0 occurs from the least hindered side (anti-attack) thus inverting the stereochemistry of the complex. Soft carbon nucleophiles and heteroatoms (such as N and O) attack in a S N 2 type manner inverting the stereochemistry of the allylpalladium complex. The overall outcome of the reaction is retention of stereochemistry. We anticipated that the stereogenic center at C 4 (the allylic benzyl ether would provide enough internal asymmetric induction for the cyclization. With 16b, the Pd catalyst would coordinate to the allylic system from the least hindered side forcing the nucleophile to replace Pd from the backside (TS anti in Scheme 5). With the anti-isomer 16a the cyclization reaction proceeded smoothly with catalytic Pd(PPh 3 ) 4 /PPh 3 in THF at 55 • C. It became immediately evident that the selectivity of the cyclisation was modest. Crude 1 H NMR showed that a~2 : 1 mixture of 17a and 17b had formed favoring the all syn (3S,4S,5S) configuration. With the synisomer 16b the selectivity rose substantially to over 9 : 1 (17c : 17d) favoring the (3S,4R,5R) configuration (overall yield 88%). The lower selectivity of 16a can possibly be explained by p-s-pisomerization of the Pd intermediate. This kind of isomerization could be feasible due to the lower energy difference between the Pd intermediates, i.e. the intermediates equilibrate more rapidly than cyclize. Hence the lower selectivity from the cyclization. Both cyclizations proceeded with high overall yields (varying between 87-95% for 17a/17b and 89-95% for 17c/17d, respectively). The relative stereochemistry of all four diastereomers were elucidated based on 1 H, 13 C & 2D NMR studies and later confirmed by the physical data of free amines 1, 2, 3 and 4.
With means of synthesizing all four diastereomers 17a-d (Scheme 6), we then investigated the cross-metathesis reaction. 25 Highest conversions (78-87%) were obtained with Grubbs' 2nd generation catalyst 26 and a 10-fold excess of 1-tetradecene in CH 2 Cl 2 at 45 • C (closed vessel). The catalyst loading had to be at least 10 mol%, otherwise the metathesis reaction did not proceed as efficiently and we could detect and isolate unreacted starting materials. The final hydrogenation and global deprotection was performed in two steps. First the double bond and benzyl ether were hydrogenated over Pd/C at an atmospheric pressure of H 2 gas. Next the t-butyl carbamate was cleaved off with HCl in MeOH at 0 • C and after basic work up Pachastrissamine 1 and its three diastereomers 2, 3 and 4 were isolated as free bases.
Conclusion
In summary, we have shown that the coupling reaction of Garner's aldehyde 5 with the vinyl lithium compound derived from the Zalkene 6 can be controlled to give either the anti or syn diastereomer in high diastereoselectivity. The open-chain allyl acetates 16a and 16b cyclise through an h 3 -allylpalladium intermediate with moderate to good stereoselectivities to tetrahydrofurans. The method presented gives easy access to Pachastrissamine 1 and all three of its diastereomers 2, 3, 4 in 9 steps starting from commercially available Garner's aldehyde 5.
Our nine step procedure provides Pachastrissamine 1 in a total yield of 13%. In comparison 1 has been synthesized from Garner's aldehyde in ten (overall yield 22%, TFA salt), 13a eleven (overall yield 11%), 13t seven (overall yield 26%) 13v and five (38%) 13x steps. Overall yields for 2, 3 and 4 were 6%, 23% and 2% respectively.
Garner's aldehyde has been also used by others for the synthesis of epi-pachastrissamines: overall yields have been 10% 13a and 43% 13x for 2, 17% for 3 and 20% for 4. 13x
Experimental General Experimental
All reactions were carried out under argon atmosphere in flamedried glassware unless otherwise noted. Non-aqueous reagents were transferred under argon via syringe or cannula and dried prior to use. Et 3 N, benzene and toluene were distilled from metallic Na. THF was distilled from Na/benzophenone, CH 2 Cl 2 from CaH 2 and DMF from molecular sieves (4 Å )/ninhydrin. Other solvents and reagents were used as obtained from supplier. Analytical TLC was performed using Merck silica gel F 254 (230-400 mesh). Column chromatography was performed using Merck silica gel 60 (230-400 mesh) and p.a. grade solvents. 1 H and 13 C NMR spectra were recorded on a Bruker Avance 400 ( 1 H 399.98 MHz; 13 C 100.59 MHz) spectrometer. The chemical shifts are reported in ppm relative to CHCl 3 (d 7.26 ppm for 1 H and 77.0 ppm for 13 C) or CHCl 2 CHCl 2 (d 5.96 ppm for 1 H and 73.7 ppm for 13 C). Melting points were determined in open capillaries using Stuart SMP3 melting point apparatus. Optical rotations were obtained with Perkin-Elmer 343 polarimeter. High resolution mass spectrometric data were measured using MicroMass LCT Premier spectrometer.
3-Iodoprop-2-yn-1-ol 10
Propargyl alcohol 7 (5.71 g, 102 mmol, 100 mol%) was dissolved in MeOH (100 mL) and cooled to 0 • C. KOH (14. 36 g, 256 mmol, 251 mol%) dissolved in H 2 O (20 mL) was added in one portion to the solution. After 10 min, iodine (28.46 g, 112 mmol, 110 mol%) was added to the solution. The mixture was stirred at 0 • C for 5 min before it was allowed to warm to room temperature. MeOH was removed under reduced pressure and the crude product was partitioned between H 2 O (100 mL) and Et 2 O (100 mL). The aqueous layer was extracted with Et 2 O (3 ¥ 100 mL). The combined organic layers were washed with sat. Na 2 SO 3 , dried (Na 2 SO 4 ) and concentrated in vacuo. The iodide 10 was collected as white crystals (15.25 g, 82%) , mp 47-49 • C. N.B. The iodide 10 can be purified by vacuum distillation (bp 80-90 • C, 15 mmHg), but 10 is also explosive at high temperatures! d H (400 MHz, CDCl 3 ) 1.85 (1H, t, J 6.1 Hz), 4.42 (2H, d, J 6.0 Hz); d C (100 MHz, CDCl 3 ) 2.6, 52.6, 92.5; EI-MS m/z 182 M + , 165, 152, 139, 127, 55 .
Preparation of potassium (E)-diazene-1,2-dicarboxylate 27
KOH (59.8 g, 1.07 mol, 250 mol%) was dissolved in distilled H 2 O (110 mL). The solution was stirred vigorously and cooled to 0 • C. Azodicarbonamide (49.7 g, 0.43 mol, 100 mol%) was added in small portions to the solution (3-5 g each) . After the addition of azodicarbonamide the mixture was stirred for 30 min before the azodicarbocylate salt was collected as a bright yellow precipitate by filtration (79.2 g, 95%). The filtrate was washed with cold H 2 O until washings were neutral, then with MeOH and finally with Et 2 O.
(Z)-3-Iodoprop-2-en-1-ol 11
Iodide 10 (30.0 g, 0.165 mol, 100 mol%) was dissolved in MeOH (400 mL) and the dipotassium diazocarboxylate (68.7 g, 0.354 mmol, 215 mol%) was added to the reaction flask. Glacial acetic acid (40.5 mL, 0.707 mmol, 430 mol%) in MeOH (100 mL) was slowly added to the solution. The rate of addition was controlled so that the solvent didn't start to boil. Gas evolution was immediate when the addition of AcOH was started and the evolved gas was released through a three-way tap. After the addition of acetic acid the contents of the flask were allowed to react for 1.5 h. MeOH was evaporated in vacuo and the residue was partitioned between H 2 O (200 mL) and CH 2 Cl 2 (100 mL). The aqueous layer was extracted with CH 2 Cl 2 (3 ¥ 100 mL). The combined organic extracts were dried (Na 2 SO 4 ) and concentrated. The residue was stirred in n-butylamine (50 mL) for 16 h. The solution was partitioned between distilled H 2 O (100 mL) and CH 2 Cl 2 (100 mL). The aqueous layer was extracted with CH 2 Cl 2 (2 ¥ 100 mL) and the combined organic layers were washed with 1 M HCl solution (200 mL). Drying of the solvents (Na 2 SO 4 ) was followed by concentration. The crude (Z)-iodide 11 was purified by filtering through a short pad (~5 cm) of silica. The iodide was collected as a pale yellow oil (19.6 
(Z)-tert-Butyl(3-iodoallyloxy)dimethylsilane 6
(Z)-iodide 11 (13.30 g, 0. 105 mol, 100 mol%) was dissolved in dry DMF (50 mL). Imidazole (15.80 g, 0.232 mol, 220 mol%) was added and allowed to dissolve before TBSCl (16.60 g, 0.105 mol, 100 mol%) was added. The reaction was complete in 30 min and pentane (100 mL) was added. Phases were separated and the DMF layer was extracted with pentane (2 ¥ 50 mL). The combined organic extracts were washed with H 2 O (50 mL), dried (Na 2 SO 4 ) and concentrated in vacuo. The crude product was purified by Kugelrohr distillation to afford the fully protected (Z)-iodide 6 as a colorless oil (30.15 g, 96%); b. 65 • C (0.15 mmHg); d H (400 MHz, CDCl 3 ) 0.11 (6H, s), 0.93 (9H, s), 4.26 (2H, dd, J 1.8, 5.3 Hz), 6.25 (1H, td, J 1.8, 7.7 Hz), 6.43 (1H, td, J 5.3, 7.7 Hz); d C (100 MHz, CDCl 3 ) -5. 2, 18.2, 25.8, 66.8, 80.0, 141 -5.37, 17.9, 24.0, 25.7, 26.3, 28.2, 59.5, 61.8, 64.2, 68.5, 80.4, 94.2, 129.1, 132.9, 152.9 ; HRMS (M + Na) + calcd for C 20 H 39 NO 5 NaSi 424.2495, found 424.2516.
(S)-4-[(Z)-(S)-4-(tert-Butyldimethylsilanyloxy)-1-hydroxybut-2enyl]-2¢,2¢-dimethyloxazolidine-3¢-carboxylic acid tert-butyl ester 12b
The (Z)-iodide 6 (2.42 g, 8.11 mmol, 201 mol%) was dissolved in dry toluene (38 mL). The flask was cooled to -78 • C and n-BuLi (2.28 M in hexanes, 3.6 mL, 8.21 mmol, 203 mol%) was added dropwise. After an hour the flask was cooled to -95 • C and BF 3 ·Et 2 O (820 mL, 6.47 mmol, 160 mol%) was added. The reaction mixture was stirred for another 30 min before the serinal 5 (926.6 mg, 4.04 mmol, 100 mol%) dissolved in toluene (6 mL) was added. The mixture was stirred at -95 • C for 2.5 h before the reaction was quenched with saturated NH 4 Cl (20 mL). The aqueous layer was extracted with EtOAc (2 ¥ 20 mL) and combined organic phases dried (Na 2 SO 4 ) and concentrated. Purification by column chromatography (15% EtOAc : hexanes) afforded 1.26 g (3.12 mmol, 77%) of 12b (syn/anti ratio 6.2 : 1); [a] 3, 61.7, 64.8, 69.3, 80.2, 94.0, 129.4, 133.7, 153.6 ; HRMS (M + Na) + calcd for C 20 H 39 NO 5 NaSi 424.2495, found 424.2511.
(S)-tert-Butyl 4-((R,Z)-1-(benzyloxy)-4-((tertbutyldimethylsilyl)oxy)but-2-en-1-yl)-2,2-dimethyloxazolidine-3carboxylate 13a
anti-Alcohol 12a (1.205 g, 3. 00 mmol, 100 mol%) was dissolved in dry THF (20 mL) and cooled to 0 • C. NaH (60% dispersion in oil, 170 mg, 4.25 mmol, 142 mol%) was added and the mixture was stirred for 15 min before TBAI (111 mg, 0.30 mmol, 10 mol%) followed by BnBr (476 mL, 4.00 mmol, 133 mol%) were added. The mixture was heated to reflux for 16 h. When the reaction was complete, the mixture was cooled to 0 • C and quenched with saturated NH 4 Cl solution (10 mL). The mixture was diluted with H 2 O (5 mL) and EtOAc (10 mL) and phases were separated. The aqueous layer was extracted with EtOAc (2 ¥ 10 mL). The combined organic phases were washed with brine, dried (Na 2 SO 4 ) and concentrated. Purification by column chromatography (20% EtOAc : hexanes) afforded the benzyl ether 13a as an oil (1.415 4, 17.9, 24.3, 25.7, 26.5, 28.2, 59.3, 60.2, 64.3, 70.5, 74.3, 79.6, 94.0, 127.2, 127.4, 128.0, 128.1, 128.3, 134.6, 138.4, 152 
(S)-tert-Butyl 4-((S,Z)-1-(benzyloxy)-4-((tertbutyldimethylsilyl)oxy)but-2-en-1-yl)-2,2-dimethyloxazolidine-3carboxylate 13b
syn-Alcohol 12b (1.260 g, 3.14 mmol, 100 mol%) was dissolved in dry THF (20 mL) and cooled to 0 • C. NaH (60% dispersion in oil, 173.3 mg, 4.33 mmol, 138 mol%) was added and the mixture was stirred for 15 min before TBAI (116 mg, 0.314 mmol, 10 mol%) followed by BnBr (480 mL, 4.03 mmol, 128 mol%) were added. The mixture was heated to reflux for 20 h. When the reaction was complete, the mixture was cooled to 0 • C and quenched with saturated NH 4 Cl solution (15 mL) . The mixture was diluted with H 2 O (5 mL) and EtOAc (10 mL) and phases were separated. The aqueous layer was extracted with EtOAc (2 ¥ 10 mL). The combined organic phases were washed with brine, dried (Na 2 SO 4 ) and concentrated. Purification by column chromatography (20% EtOAc : hexanes) afforded the benzyl ether 13b as an oil (1.420 g, 92%) ; [a] 3.92 (1H, dd, J 6.5, 9.6 Hz), 4.08 (1H, ddd, J 1.8, 4.5, 13.5 Hz), m), 4.18 (1H, dd, J 1.4, 9.5 Hz), 4.32 (1H, m), 4.42 (1H, d, J 12.0 Hz), 4.62 (1H, d, J 11.9 Hz), m), 5.50 (1H, app. tdd, J 1.6, 9.9, 11.4 Hz), 5.89 (1H, app. ddd, J 4.2, 7.3, 11.4 Hz), m) ; d C (100 MHz, CDCl 3 , 60 • C) d -5.14, -5.12, 18.2, 24.3, 25.9, 26.3, 28.5, 59.4, 60.1, 63.6, 70.8, 72.9, 79.9, 94.4, 126.8, 127.5, 127.7, 128.3, 136.6, 138.8, 152 4-((R,Z)-1-(benzyloxy)-4-hydroxybut-2-en-1-yl) 
-2,2-dimethyloxazolidine-3-carboxylate 14a
Benzyl ether 13a (1.40 g, 2. 85 mmol, 100 mol%) was dissolved in THF (20 mL) . To this solution was added TBAF (1 M in THF, 3.0 mol, 3.0 mmol, 105 mol%). The reaction was complete in 15 min and the solvent was evaporated in vacuo. The crude alcohol was purified by column chromatography (30% EtOAc : hexanes) to afford the anti-acohol 14a as a viscous oil (966 mg, 90%); [a] D -40.3 (c 1.88, CH 2 Cl 2 ); IR (neat) 3449, 3089, 3064, 2979, 2935, 2874, 1698, 1608, 1587 1H, ddd, J 1.3, 6.1, 13 .0 Hz), 4.15 (1H, m), 4.20 (1H, ddd, J 1.0, 7.3, 13.1 Hz), 4.39 (1H, d, J 11.9 Hz), 4.52 (1H, m), 4.31 (1H, d, J 11.9 Hz), 5.52 (1H, app. dd, J 9.8, 10.8 Hz), 5.87 (1H, dddd, J 1.0, 6.2, 7.1, 11.3 Hz) , 7. 23-7.35 (5H, m) ; d C (100 MHz, CDCl 3 , 50 • C) 24.6, 26.7, 28.4, 58.6, 60.8, 64.3, 70.9, 74.0, 80.3, 94.3, 127.6, 127.8, 128.3, 130.8, 133.5, 138.3, 152.7; HRMS calcd. for C 21 H 31 NO 5 Na [M + +Na] 400.2100, found 400.2097.
(S)-tert-Butyl 4-((S,Z)-1-(benzyloxy)-4-hydroxybut-2-en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate 14b
Benzyl ether 13b (1.340 g, 2. 73 mmol, 100 mol%) was dissolved in THF (20 mL) . To this solution was added TBAF (1 M in THF, 3.0 mol, 3.0 mmol, 110 mol%). The reaction was complete in 15 min and the solvent was evaporated in vacuo. The crude alcohol was purified by column chromatography (30% EtOAc : hexanes) to afford the syn-alcohol 14b as a viscous oil (945 mg, 92%); [a] D +3.2 (c 1.05, CH 2 Cl 2 ); IR (neat) 3437, 3060, 2978 , 2935 , 2875 , 1698 , 1601 , 1585 d H (400 MHz, CDCl 3 , 50 • C) 1.46 (9H, s), 1.47 (3H, s), 1.52 (3H, s), 1.75-1.85 (1H, br s), 3.93 (1H, dd, J 6.9, 9.5 Hz), 4.07 (1H, dd, J 5.7, 13.3 Hz), m), 4.17 (1H, dd, J 7.2, 12.9 Hz), 4.21 (1H, dd, J 1.4, 9.6 Hz) 3, 26.5, 28.4, 58.7, 59.8, 63.5, 70.9, 72.5, 80.4, 94.3, 127.64, 127.68, 128.4, 128.7, 135.0, 138.5, 152.8; HRMS calcd. for C 21 H 31 NO 5 Na [M + +Na] 400.2100, found 400.2094.
(S)-tert-Butyl 4-((R,Z)-4-acetoxy-1-(benzyloxy)but-2-enyl)-2,2dimethyloxazolidine-3-carboxylate 15a
Alcohol 14a (802 mg, 2.12 mmol, 100 mol%) was dissolved in CH 2 Cl 2 (20 mL) at room temperature. To this solution were added DMAP (51.0 mg, 0.42 mmol, 20 mol%), Et 3 N (592 ml, 4.25 mmol, 200 mol%) and finally Ac 2 O (324 mL, 3.44 mmol, 162 mol%). The reaction was complete in 10 min. Solvents were evaporated in vacuo and the crude acetate was purified by column chromatography (50% EtOAc : hexanes) to afford the the anti-acetate 15a as a colourless oil (850 mg, 95%); [a] D -52.4 (c 1.31, CH 2 Cl 2 ); IR (neat) 3089, 3065, 3030, 2977, 2933, 2873, 1739, 1698, 1607, 1587 28.4, 60.0, 60.3, 64.6, 71.0, 74.3, 80.1, 93.1, 126.8, 127.9, 128.4 ., 129.6, 133.0, 138.4, 152.1, 170.5; HRMS calcd. for C 23 H 33 
(S)-tert-Butyl 4-((S,Z)-4-acetoxy-1-(benzyloxy)but-2-en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate 15b
Alcohol 14b (925 mg, 2.45 mmol, 100 mol%) was dissolved in CH 2 Cl 2 (10 mL) at room temperature. To this solution were added DMAP (20.0 mg, 0.164 mmol, 7 mol%), Et 3 N (520 mL, 3.68 mmol, 150 mol%) and finally Ac 2 O (255 mL, 2.70 mmol, 110 mol%). The reaction was complete in 15 min. Solvents were evaporated in vacuo and the crude acetate was purified by column chromatography (50% EtOAc : hexanes) to afford the the syn-acetate 15b as a colourless oil (980 mg, 95%); [a] D -2.5 (c 1.09, CH 2 Cl 2 ); IR (neat) 3065, 3031, 2977, 2930, 2873, 1742, 1699, 1605 3.93 (1H, dd, J 6.5, 9.6 Hz), m), 4.19 (1H, dd, J 1.0, 9.6 Hz), 4.39 (1H, d, J 11.8 Hz), br s), 4.61 (1H, d, J 11.9 Hz), 4.73 (1H, dd, J 7.4, 13.1 Hz), 5.69 (1H, tdd, J 1.3, 9.8, 11.3 Hz), 5.87 (1H, m), m) ; d C (100 MHz, CDCl 3 , 50 • C) 20.7, 24.1, 25.6, 28.4, 60.0, 60.2, 63.5, 70.9, 72.4, 80.1, 94.5, 127.7, 127.9, 128.4, 130.0, 131.1, 138.5, 152.5, 170.4; HRMS calcd. for C 23 H 33 NO 6 Na [M + +Na] 442.2203, found 442.2209.
(4R,5S,Z)-4-(Benzyloxy)-5-((tert-butoxycarbonyl)amino)-6hydroxyhex-2-en-1-yl acetate 16a
anti-Acetate 15a (690 mg, 1.65 mmol, 100 mol%) was dissolved in chloroform (15 mL) . To this vigorously stirred solution was added FeCl 3 -SiO 2 (680 mg). The mixture was stirred for 12 h before solvents were evaporated. The crude alcohol was purified by column chromatography to afford 16a as a highly viscous oil (574.5 mg, 92%); [a] D -48.6 (c 1.11, CH 2 Cl 2 ); IR (neat) 3423, 3067, 3034, 2976, 2930, 2870, 1741, 1698 3.67 (1H, dd, J 3.7, 11.3 Hz), 3.95 (1H, dd, J 3.0, 11.2 Hz), 4.34 (1H, d, J 11.8 Hz), 4.42 (1H, dd, J 5.3, 8.7 Hz), 4.58 (1H, dd, J 6.2, 12.3 Hz), 4.61 (1H, d, J 11.8 Hz), 4.68 (1H, dd, J 7.5, 13.2 Hz), 5.23 (1H, d, J 3.8 Hz), 5.67 (1H, app. dd, J 9.5, 10.9 Hz), 5.84 (1H, dddd, J 0.8, 6.2, 7.2, 11.3 Hz), m) ; d C (100 MHz, CDCl 3 ) 20.9, 28. 3, 54.8, 60.0, 62.3, 71.0, 75.8, 79.5, 127.8, 128.0, 128.5, 129.1, 132.0, 137.5, 155.7, 170.8; HRMS calcd. for C 20 H 29 NO 6 Na [M + +Na] 402.1893, found 402.1884.
(4S,5S,Z)-4-(Benzyloxy)-5-((tert-butoxycarbonyl)amino)-6hydroxyhex-2-en-1-yl acetate 16b
syn-Acetate 15b (950 mg, 2.27 mmol, 100 mol%) was dissolved in chloroform (20 mL) . To this vigorously stirred solution was added FeCl 3 -SiO 2 (1.03 g). The mixture was stirred for 12 h before solvents were evaporated. The crude alcohol was purified by column chromatography (30% EtOAc : hexanes) to afford 16b as a highly viscous oil (740 mg, 86%); [a] D +11.6 (c 1.14, CH 2 Cl 2 ); IR (neat) 3445, 3065, 3031, 2978, 2932, 2871, 1739, 1695 m), 4.34 (1H, d, J 11.7 Hz), 4.43 (1H, dd, J 1.3, 9.0 Hz), 4.57 (1H, m), 4.59 (1H, d, J 11.6 Hz), 4.64 (1H, ddd, J 0.9, 7.0, 13.1 Hz), br s), 5.66 (1H, dd, J 9.8, 11.0 Hz), 5.83 (1H, app. td, J 6.7, 11.5 Hz), (5H, m); d C (100 MHz, CDCl 3 ) 20.9, 28.3, 55.6, 60. 1, 63.3, 70.5, 73.7, 79.7, 127.8, 127.9, 128.5, 129.1, 131.4, 137.6, 156.2, 170.7; HRMS calcd. for C 20 H 29 NO 6 Na [M + +Na] 402.1893, found 402.1898.
Formation of the furan ring
anti-Alcohol 16a (305 mg, 0.805 mmol, 100 mol%) was dissolved in dry THF (15 mL) . To this solution were added PPh 3 (27.2 mg, 0.104 mmol, 12 mol%) and Pd(PPh 3 ) 4 (60.0 mg, 0.0519, 6 mol%). The flask was sealed, placed in an oil bath and heated to 55 • C. After 8 h the reaction was complete and the solution was concentrated. The crude product was purified by column chromatography (20% EtOAc : hexanes) to afford 17a (152 mg, 59%) and 17b (73 mg, 28%). Butyl ((3S,4R,5S )-4-(benzyloxy)-5-vinyltetrahydrofuran-3yl)carbamate 17d. [a] D -33.2 (c 0.39, CH 2 Cl 2 ); IR (neat) 3338, 3065, 3031, 2978, 2930, 2872, 1710 cm -1 ; d H (400 MHz, CDCl 3 ) 1.45 (9H, s), 3.68 (1H, d, J 3.4 Hz), 3.83 (1H, d, J 9.7 Hz), 4.05 (1H, dd, J 4.8, 9.7 Hz), 4.21 (1H, m), 4.25 (1H, m), 4.62 (1H, d, J 12.0 Hz), 4.71 (1H, m), 4.78 (1H, d, J 11.9 Hz), 5.17 (1H, app. td, J 1.2, 10.4 Hz), 5.35 (1H, app. td, J 1.3, 17.2 Hz), 5.87 (1H, ddd, J 5.9, 10.5, 17.2 Hz), m) ; d C (100 MHz, CDCl 3 ) 28. 4, 56.5, 71.7, 72.2, 79.8, 85.0, 88.7, 116.3, 127.8, 127.9, 128.4, 136.3, 137.8, 155.0; HRMS calcd. for C 18 H 25 NO 4 Na [M + +Na] 342.1681, found 342.1688. Butyl ((3S,4S,5S)-4-(benzyloxy)-5-((E)-tetradec-1-en-1yl) 
tert-

tetrahydrofuran-3-yl)carbamate 18a
Furan 17a (43 mg, 0.135 mmol, 100 mol%) was dissolved in dry CH 2 Cl 2 (4 mL). To this solution was added 1-tetradecene (350 mL, 1.33 mmol, 10 equiv) and 5 min later Grubbs' catalyst (2nd generation, 14.6 mg, 0.017, 13 mol%). The flask was sealed, placed in an oil bath and stirred at 45 • C for 18 h. When the reaction was complete, the mixture was concentrated in vacuo. 1, 7.7, 15.5 Hz), 5.80 (1H, td, J 6.7, 15.4 Hz), 7.28-7.37 (5H, m); d C (100 MHz, CDCl 3 ) 14. 5, 23.1, 28.8, 29.4, 29.7, 29.8, 29.9, 30.00, 30.04, 30.1, 32.3, 32.8, 53.4, 70.9, 74.1, 80.0, 80.3, 83.0, 125.9, 128.2, 128.3, 128.9, 136.2, 138.1, 156 
tert-Butyl ((3S,4S,5R)-4-(benzyloxy)-5-((E)-tetradec-1-en-1yl)tetrahydrofuran-3-yl)carbamate 18b
Furan 17b (31.5 mg, 0.099 mmol, 100 mol%) was dissolved in dry CH 2 Cl 2 (3 mL). To this solution was added 1-tetradecene (250 mL, 0.982 mmol, 10 equiv) and 10 min later Grubbs' catalyst (2nd generation, 8.9 mg, 0.010, 11 mol%). The flask was sealed, placed in an oil bath and stirred at 45 • C for 16 h. When the reaction was complete, the mixture was concentrated in vacuo. The crude product was purified by column chromatography (100% hexanes → 20% EtOAc : hexanes). Yield of 18b (41.0 mg, 85%); [a] 1, 22.7, 28.3, 28.9, 29.2, 29.3, 29.48, 29.58, 29.62, 29.67, 31.9, 32.2, 51.4, 71.2, 72.2, 79.6, 81.9, 83.0, 127.6, 127.7, 127.8, 128.0, 134.6, 137.4, 155.7 Butyl ((3S,4R,5R)-4-(benzyloxy)-5-((E)-tetradec-1-en-1 
tert-
yl)tetrahydrofuran-3-yl)carbamate 18c
Furan 17c (41 mg, 0.128 mmol, 100 mol%) was dissolved in dry CH 2 Cl 2 (3 mL) . To this solution was added 1-tetradecene (335 mL, 1.32 mmol, 10 equiv) and 5 min later Grubbs' catalyst (2nd generation, 16.7 mg, 0.020, 15 mol%). The flask was sealed, placed in an oil bath and stirred at 45 • C for 18 h. When the reaction was complete, the mixture was concentrated in vacuo. The crude product was purified by column chromatography (100% hexanes → 20% EtOAc : hexanes). Yield of 18c (50.6 mg, 81%); [a] D -16.8 (c 1.01, CH 2 Cl 2 ); IR (neat) 3341, 3065, 3030, 2978, 2930, 2862 , 1712 cm -1 ; d H (400 MHz, CDCl 3 ) 0.88 (3H, t, J 6.9 Hz), 1.26 (20H, m), 1.35-1.43 (2H, m), 1.46 (9H, s), 2.08 (2H, app. q, J 6.9 Hz), 3.56 (1H, dd, J 4.5, 11.4 Hz), 3.81 (1H, d, J 4.1 Hz), 4.24 (2H, m), 4.31 (1H, dd, J 4.2, 6.9 Hz), 4.62 (1H, d, J 12.2 Hz), 4.70 (1H, d, J 5.6 Hz), 4.76 (1H, d, J 12.2 Hz), 5.68 (1H, app. dd, J 7.5, 15.5 Hz), 5.76 (1H, td, J 6.2, 15.5 Hz), (5H, m); d C (100 MHz, CDCl 3 ) 14. 1, 22.7, 28.3, 29.0, 29.2, 29.3, 29.51, 29.57, 29.62, 29.66, 31.9, 32.4, 56.5, 71.0, 71.5, 79.8, 81.8, 84.7, 124.8, 127.47, 127.53, 128.2, 135.8, 138.2, 155. 
tert-Butyl ((3S,4R,5S)-4-(benzyloxy)-5-((E)-tetradec-1-en-1yl)tetrahydrofuran-3-yl)carbamate 18d
Furan 17d (18.5 mg, 0.058 mmol, 100 mol%) was dissolved in dry CH 2 Cl 2 (2 mL). To this solution was added 1-tetradecene (150 ml, 0.59 mmol, 10 equiv) and 5 min later Grubbs' catalyst (2nd generation, 9.3 mg, 0.011, 19 mol%). The flask was sealed, placed in an oil bath and stirred at 45 • C for 16 h. When the reaction was complete, the mixture was concentrated in vacuo. The crude product was purified by column chromatography (100% hexanes → 20% EtOAc : hexanes). Yield of 18d (22.0 mg, 78%); [a] D -14.9 (c 1.10, CH 2 Cl 2 ); IR (neat) 3340, 3065, 3030, 2977, 2932, 2860, 1712 cm -1 ; d H (400 MHz, CDCl 3 ) 0.88 (3H, t, J 6.9 Hz), 1.26 (20H, m), 1.32-1.39 (2H, m), 1.46 (9H, s), 2.03 (2H, app. q, J 7.0 Hz), 3.63 (1H, app. d, J 3.8 Hz), 3.79 (1H, d, J 9.5 Hz), 4.01 (1H, dd, J 4.8, 9.7 Hz), 4.18 (2H, m), 4.62 (1H, d, J 12.0 Hz), 4.76 (1H, d, J 12.0 Hz), m), 5.44 (1H, app. dd, J 7.0, 15.4 Hz), 5.77 (1H, tdd, J 0.8, 6.9, 15.5 Hz), m) ; d C (100 MHz, CDCl 3 ) 14. 1, 22.7, 28.4, 29.0, 29.2, 29.3, 29.49, 29.58, 29.63, 29.67, 31.9, 32.3, 56.7, 71.6, 72.0, 79.7, 85.1, 88.9, 127.7, 127.82, 127.84, 134.3, 137.9, 155. Butyl ((3S,4S,5S) 
tert-
-4-hydroxy-5-tetradecyltetrahydrofuran-3yl)carbamate
Compound 18a (45.0 mg, 0.0923 mmol, 100 mol%) was dissolved in MeOH (3 mL) . To this solution was added 10 wt-% Pd/C (9.8 mg, 0.0092 mmol, 10 mol%). The flask was evacuated and the atmosphere was first changed to Ar and finally to H 2 (balloon). The mixture was allowed to react for 8 h before it was filtered through a pad of Celite, followed by evaporation of solvents. This Boc-protected compound was used as such in the following step; [a] D +1.4 (c 1.29, CH 2 Cl 2 ); d H (400 MHz, CDCl 3 , 50 • C) 0.88 (3H, t, J 6.9 Hz), 1.22-1.35 (24H, br m), 1.45 (9H, s), 1.57-1.65 (2H, m), 2.6 (1H, br s), 3.57 (1H, t, J 8.2 Hz), 3.78 (1H, td, J 2.9, 6.8 Hz), 4.02 (1H, t, J 8.4 Hz), 4.06 (1H, dd, J 3.1, 4.6 Hz), 4.27
